Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
- PMID: 11189685
- DOI: 10.1016/s0197-2456(00)00099-4
Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
Abstract
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial is a large and complex multi-institutional, multifaceted organization with a 20-year horizon. The implementation of the trial began with the creation of an organizational structure that supports strong leadership, cooperation, and effective communication among the trial collaborators including an operational framework for the development, review, and pretest of instruments, data collection, and management procedures; the setting of high-quality standards for training of trial staff; and the development of a comprehensive assessment plan for evaluation of all trial activities. This paper describes the process and methods used in the coordination and management of the PLCO trial. These include the role of the steering committee and its subcommittees and working groups, the establishment of regular and ad hoc communications among collaborators, the training of screening center coordinators and examiners, the PLCO manual of operations and procedures, and the development and implementation of a comprehensive quality assurance plan.
Similar articles
-
Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.Control Clin Trials. 2000 Dec;21(6 Suppl):390S-399S. doi: 10.1016/s0197-2456(00)00094-5. Control Clin Trials. 2000. PMID: 11189690
-
Comprehensive Quality Management (CQM) in the PLCO Trial.Rev Recent Clin Trials. 2015;10(3):223-32. doi: 10.2174/1574887110666150730121113. Rev Recent Clin Trials. 2015. PMID: 26238118
-
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.Control Clin Trials. 2000 Dec;21(6 Suppl):400S-406S. doi: 10.1016/s0197-2456(00)00095-7. Control Clin Trials. 2000. PMID: 11189691
-
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.Rev Recent Clin Trials. 2015;10(3):173-80. doi: 10.2174/1574887110666150730123004. Rev Recent Clin Trials. 2015. PMID: 26238115 Review.
-
Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial.Rev Recent Clin Trials. 2015;10(3):187-93. doi: 10.2174/157488711003150928123938. Rev Recent Clin Trials. 2015. PMID: 26435288 Review.
Cited by
-
Cumulative incidence of false-positive results in repeated, multimodal cancer screening.Ann Fam Med. 2009 May-Jun;7(3):212-22. doi: 10.1370/afm.942. Ann Fam Med. 2009. PMID: 19433838 Free PMC article. Clinical Trial.
-
Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.Tumour Biol. 2016 Aug;37(8):10177-85. doi: 10.1007/s13277-016-4883-7. Epub 2016 Jan 29. Tumour Biol. 2016. PMID: 26831660 Clinical Trial.
-
PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies.Rev Recent Clin Trials. 2015;10(3):238-45. doi: 10.2174/157488711003150928130654. Rev Recent Clin Trials. 2015. PMID: 26435289 Free PMC article. Review.
-
Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial.Cytokine. 2011 Nov;56(2):145-8. doi: 10.1016/j.cyto.2011.06.012. Epub 2011 Jul 20. Cytokine. 2011. PMID: 21764327 Free PMC article.
-
The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.J Natl Cancer Inst. 2013 Nov 20;105(22):1684-93. doi: 10.1093/jnci/djt281. Epub 2013 Oct 10. J Natl Cancer Inst. 2013. PMID: 24115361 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical